The current landscape of quinazoline derivatives with in vivo anticancer therapeutic potential-part II

Area of Science:

• Medicinal Chemistry
• Oncology
• Pharmacology

Background:

• Cancer remains a leading global cause of death, with drug resistance posing a significant challenge.
• Multidrug resistance in cancer necessitates the development of novel chemotherapeutic agents.
• Quinazoline derivatives are recognized for their diverse anticancer activities and established therapeutic roles.

Purpose of the Study:

• To review the in vivo anticancer potential of quinazoline derivatives.
• To explore the mechanisms of action, toxicity, and pharmacokinetics of these compounds.
• To provide an updated overview of recent advancements in quinazoline-based cancer therapeutics.

Main Methods:

• Comprehensive literature search for studies published from 2015 to the present.
• Analysis of research focusing on quinazoline derivatives with demonstrated in vivo anticancer activity.
• Evaluation of reported mechanisms, toxicity profiles, and pharmacokinetic data.

Main Results:

• Quinazoline derivatives exhibit anticancer effects via cell cycle arrest, apoptosis induction, and autophagy modulation.
• Several quinazoline-based agents have shown significant in vivo efficacy in preclinical models.
• The review details the therapeutic potential, safety, and drug-like properties of various derivatives.

Conclusions:

• Quinazoline derivatives represent a valuable class of compounds for developing next-generation anticancer therapies.
• Understanding their mechanisms and properties is crucial for advancing their clinical application.
• Continued research into quinazoline derivatives holds significant promise for overcoming cancer drug resistance.